Gonadotropin-Releasing Hormone Agonists and Bone Density in Congenital Adrenal Hyperplasia: A Call for Further Research

被引：0
|
作者：
Bakhtiani, Priyanka [1 ,2 ]
机构：
[1] Univ Southern Calif, Childrens Hosp Los Angeles, Keck Sch Med, Ctr Endocrinol Diabet & Metab,Dept Pediat, Los Angeles, CA 90026 USA
[2] Univ Southern Calif, Childrens Hosp Los Angeles, Keck Sch Med, Ctr Endocrinol Diabet & Metab,Dept Pediat, 4650 Sunset Blvd, Mail Stop 61, Los Angeles, CA 90026 USA
来源：
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2024年 / 109卷 / 06期
关键词：
congenital adrenal hyperplasia; early puberty; GnRH agonist; bone mineral density; short stature; adrenal; ADULT HEIGHT; ANALOGS;
D O I：
10.1210/clinem/dgad687
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：e1458 / e1459
页数：2
相关论文
共 50 条
  • [41] Use of an aromatase inhibitor in children with congenital adrenal hyperplasia: Impact of anastrozole on bone mineral density and visceral adipose tissue
    Halper, Alyssa
    Sanchez, Belen
    Hodges, James S.
    Dengel, Donald R.
    Petryk, Anna
    Sarafoglou, Kyriakie
    CLINICAL ENDOCRINOLOGY, 2019, 91 (01) : 124 - 130
  • [42] Bone mineral density and body composition in girls with idiopathic central precocious puberty before and after treatment with a gonadotropin-releasing hormone agonist
    Alessandri, Sandra B.
    Pereira, Francisco de A.
    Villela, Rosangela A.
    Antonini, Sonir R. R.
    Elias, Paula C. L.
    Martinelli, Carlos E., Jr.
    de Castro, Margaret
    Moreira, Ayrton C.
    de Paula, Francisco J. A.
    CLINICS, 2012, 67 (06) : 591 - 596
  • [43] Bone resorption starts at 14 days of treatment with gonadotropin-releasing hormone agonist in in vitro fertilization cycles
    Yilmaz, H
    Ozgur, K
    Isikoglu, M
    Sonmez, C
    Uner, M
    GYNECOLOGICAL ENDOCRINOLOGY, 2004, 19 (01) : 40 - 46
  • [44] Effect of long-term glucocorticoid therapy on bone mineral density of the patients with congenital adrenal hyperplasia
    Unal, Sezin
    Alikasifoglu, Ayfer
    Ozon, Alev
    Gonc, Nazli
    Kandemir, Nurgun
    TURKISH JOURNAL OF PEDIATRICS, 2020, 62 (03) : 359 - 366
  • [45] Bone Mineral Density in Girls with Classical Congenital Adrenal Hyperplasia due to CYP21 Deficiency
    Elnecave, Regina Helena
    Kopacek, Cristiane
    Rigatto, Marilia
    Brenner, Juliana Keller
    Sisson de Castro, Jose Augusto
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2008, 21 (12): : 1155 - 1162
  • [46] Ovarian protection with gonadotropin-releasing hormone agonists during chemotherapy in cancer patients: From biological evidence to clinical application
    Lambertini, Matteo
    Horicks, Florence
    Del Mastro, Lucia
    Partridge, Ann H.
    Demeestere, Isabelle
    CANCER TREATMENT REVIEWS, 2019, 72 : 65 - 77
  • [47] Gonadotropin-releasing hormone agonists for ovarian protection during breast cancer chemotherapy: a systematic review and meta-analysis
    Li, Zhen-Yu
    Dong, Ying-Li
    Cao, Xiao-Zhong
    Ren, Sha-Sha
    Zhang, Zhen
    MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY, 2022, 29 (09): : 1093 - 1100
  • [48] The Hormonal Profile of Norethindrone Acetate: Rationale for Add-Back Therapy With Gonadotropin-Releasing Hormone Agonists in Women With Endometriosis
    Kristof Chwalisz
    Eric Surrey
    Frank Z. Stanczyk
    Reproductive Sciences, 2012, 19 : 563 - 571
  • [49] Effect of gonadotropin-releasing hormone agonists on monocyte chemotactic protein-1 production and macrophage infiltration in leiomyomatous uterus
    Sozen, I
    Senturk, LM
    Arici, A
    FERTILITY AND STERILITY, 2001, 76 (04) : 792 - 796
  • [50] The Hormonal Profile of Norethindrone Acetate: Rationale for Add-Back Therapy With Gonadotropin-Releasing Hormone Agonists in Women With Endometriosis
    Chwalisz, Kristof
    Surrey, Eric
    Stanczyk, Frank Z.
    REPRODUCTIVE SCIENCES, 2012, 19 (06) : 563 - 571
12345